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Abstract 
Background Restoration of blood supply to the heart after a prolonged 
ischaemic episode causes myocardial ischaemia-reperfusion (I/R) injury. 
Paradoxically, short periods of ischaemia and reperfusion, known as 
preconditioning, has a potent cardioprotective effect. One key aspect of I/R 
injury is cytotoxic mitochondrial fission that allows cytochrome c release and 
promotes apoptotic cell death. Dynamin-related protein 1 (Drp1) is a large 
GTPase that is recruited from the cytosol to the mitochondrial outer 
membrane to drive fission. Drp1 function is regulated by posttranslational 
modifications, including conjugation to small ubiquitin-like modifier 
(SUMO)−2/3. SUMO-2/3-ylation decreases Drp1 partitioning to the 
mitochondrial membrane, which reduces stress-induced fission and 
apoptosis. We have shown previously that, in neurons, Drp1 SUMO-2/3-
ylation is controlled by the deSUMOylating enzyme SENP3, levels of which 
are reduced during ischaemia but restored upon reperfusion. 
Objective Here we investigated alterations in SUMOylation and Drp1 
partitioning in heart during ischaemia, I/R and preconditioning. Methods: 
Isolated hearts from male Wistar rats were perfused using Langendorff 
apparatus with Krebs Henseleit solution. Hearts were randomly divided into 4 
groups (with n=5Ð6 per group): control (50 min perfusion); ischaemia (20 min 
perfusion+30 min ischaemia); preconditioning (3 short cycles of I/R, 2 and 3 
mins, respectively, followed by 30 min of ischaemia); I/R (30 min of ischaemia 
followed by 2 hour of reperfusion). All samples were immediately subjected to 
subcellular fractionation, then frozen on dry ice and used for Western blot 
analysis. 
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Results Levels of SENP3 were reduced in all three groups compared to 
control, with the greatest reduction seen during ischaemia (Fig 1A). Despite 
the observed reduction in SENP3 levels no obvious change in overall levels of 
protein SUMO-2/3-ylation was detected in mitochondria fractions (Fig 1B). An 
increase of SUMO-1 conjugation to an unidentified protein at about 55 kDa 
was observed during ischaemia and I/R compared to both the control and 
preconditioning groups (Fig 2A). Intriguingly, in contrast to our finding in 
neurons, where mitochondrial partitioning of Drp1 decreases during 
ischaemia, in cardiac tissue we observed recruitment of Drp1 to mitochondria, 
with no change in total protein levels. Furthermore, Drp1 recruitment to 
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mitochondria was increased by preconditioning. In the I/R group, in which 
cells are undergoing apoptosis, levels of Drp1 at the mitochondria are similar 
to controls (Fig 2B). 
 
Conclusion Taken together our data suggest a delicate balance between 
SUMOylation and deSUMOylation that regulates the recruitment of Drp1 to 
mitochondria. This pathway plays an important role in the vulnerability of 
cardiomyocytes to ischaemic damage and myocardial reperfusion injury. 
Interestingly, the interplay between the relevant proteins appears to differ 
between heart and brain cells. 
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